![Chemistry / Organic chemistry / Pharmacology / (-)-2β-(1 / 2 / 4-Oxadiazol-5-methyl)-3β-phenyltropane / Methylecgonidine / Nuclear magnetic resonance spectroscopy / Phenyltropane / Nuclear magnetic resonance / RTI-120 / Tropanes / Dopamine reuptake inhibitors / Stimulants Chemistry / Organic chemistry / Pharmacology / (-)-2β-(1 / 2 / 4-Oxadiazol-5-methyl)-3β-phenyltropane / Methylecgonidine / Nuclear magnetic resonance spectroscopy / Phenyltropane / Nuclear magnetic resonance / RTI-120 / Tropanes / Dopamine reuptake inhibitors / Stimulants](https://www.pdfsearch.io/img/7acb76c821a3a1da7f1eab6c8b2a06b1.jpg) Date: 2014-03-13 16:49:51Chemistry Organic chemistry Pharmacology (-)-2β-(1 2 4-Oxadiazol-5-methyl)-3β-phenyltropane Methylecgonidine Nuclear magnetic resonance spectroscopy Phenyltropane Nuclear magnetic resonance RTI-120 Tropanes Dopamine reuptake inhibitors Stimulants | | Characterization of 2β-(1,2,4-Oxadiazol-5-methyl)-3β-phenyltropane (“RTI-126”) John F. Casale* and Patrick A. Hays U.S. Department of Justice Drug Enforcement Administration Special Testing and Research Laboratory Add to Reading ListSource URL: www.justice.govDownload Document from Source Website File Size: 665,26 KBShare Document on Facebook
|